The RAYS Act (HR 7092) requires secondary schools to include suicide prevention contact information on student identification cards or, if cards aren't issued, on school websites and student-accessible online platforms. Schools must list the 988 Suicide and Crisis Lifeline, Crisis Text Line, and a local suicide prevention hotline. The bill also allows schools to optionally add more mental health resources and mandates federal outreach to inform students, parents, and staff about these services. It takes effect one year after enactment for physical ID cards and 60 days later for digital methods.
This bill (HR 2199) prevents private health insurance plans from discriminating against patients with end-stage kidney disease (ESRD) who require dialysis. It amends the Social Security Act to prohibit plans from treating dialysis coverage differently than other medical services or applying network restrictions that disproportionately harm ESRD patients. The law clarifies that plans cannot deny or limit benefits for dialysis based on a patient’s diagnosis, while preserving a plan’s right to choose which dialysis providers are in their network. It directly affects ESRD patients and their private health insurance coverage, ensuring dialysis is treated equally with other covered medical services. The bill does not require plans to include specific dialysis providers but stops them from unfairly restricting access to necessary care.
This bill prohibits the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) from treating pregnancy as an illness when approving or regulating abortion drugs. It specifically bans using this framework for approvals under the Federal Food, Drug, and Cosmetic Act or for risk management strategies. The bill also nullifies existing approvals of abortion drugs (like mifepristone) that relied on treating pregnancy as an illness. This directly affects how the FDA regulates abortion medications, changing the basis for their safety and efficacy evaluations.
HR 72, the TBI and PTSD Treatment Act, authorizes the Department of Veterans Affairs to provide hyperbaric oxygen therapy as a covered treatment for veterans diagnosed with traumatic brain injury (TBI) or post-traumatic stress disorder (PTSD). This bill directly affects eligible veterans with these specific conditions by expanding their access to this treatment option through VA-approved health care providers. The key provision adds a new section (1710F) to Title 38, specifying that the Secretary must furnish this therapy under existing VA healthcare authority. The bill does not create new benefits but formalizes coverage for this specific treatment method for qualifying veterans.
This bill prohibits states from pursuing or collecting Medicaid recovery claims against individuals' estates for payments made during their lifetime. It requires states to withdraw all existing recovery liens within 90 days of enactment and notify affected individuals or their estates. The law specifically ends state efforts to reclaim Medicaid funds from beneficiaries' estates after death, applying to claims initiated before the law's effective date. It directly affects Medicaid beneficiaries and their estates who were subject to prior state recovery actions. The key mechanism is a mandatory 90-day withdrawal of all existing liens and a permanent ban on new recovery claims for correctly paid assistance.
HR 6682, the Endometriosis CARE Act, requires federal agencies to advance research, improve treatment access, and increase awareness for people with endometriosis - a chronic condition causing pelvic pain and fertility challenges affecting an estimated 10% of reproductive-age individuals. The bill mandates $50 million annually for NIH research on endometriosis treatments and cures, directs HHS to analyze barriers like insurance coverage and provider shortages in accessing care, and funds public education campaigns targeting underserved racial, ethnic, and minority groups. It also requires HHS to develop provider training materials on diagnosis and care, and to commission a National Academies study on disparities in endometriosis treatment across race, geography, and insurance status. The legislation focuses on data collection, education, and research rather than altering existing insurance coverage or treatment protocols.
S 717, the *Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025*, expands Medicare coverage for cardiac and pulmonary rehabilitation programs by broadening which healthcare providers can prescribe these services. The bill amends Medicare rules to allow physician assistants, nurse practitioners, and clinical nurse specialists (in addition to physicians) to prescribe exercise and rehabilitation programs under Medicare Part B. This change directly affects Medicare beneficiaries requiring cardiac or pulmonary rehab, making it easier to access care from a wider range of qualified providers. The key provision removes restrictive language limiting prescriptions to "physicians" and updates definitions to include these additional provider types, effective six months after enactment.
The Gun Safety Board and Research Act establishes a 22-member board within the Department of Health and Human Services to conduct and fund research on firearm violence reduction. The board must create a research program using at least half of its $5 million annual funding (rising to $25 million yearly), focusing on topics like domestic violence, suicide prevention, mass shootings, and health care costs, while publishing annual reports with policy recommendations and research gaps. It directly affects public health researchers, law enforcement, victims' advocates, and policymakers by generating evidence-based insights for federal, state, and local action. The board includes diverse expertise - from trauma surgery to firearm manufacturing - and must evaluate existing laws' effectiveness, avoiding advocacy while detailing concrete research priorities.
This bill reauthorizes federal grant programs supporting telehealth networks and resource centers through the Public Health Service Act. It provides $42.05 million annually for fiscal years 2026 through 2030 to fund these programs. The key provision is the specific, multi-year funding amount for existing telehealth infrastructure and support services. These grants directly support healthcare providers and community organizations that expand remote medical services. The bill makes no changes to program eligibility or structure, only extending funding authorization.
HR 2810, the Family Cord Blood Banking Act, allows individuals to deduct payments for private umbilical cord blood or tissue banking as medical expenses on their federal taxes. It directly affects people who pay for these private banking services through accredited providers meeting specific federal safety standards. The bill amends the tax code to add private cord banking services as a qualifying medical expense, effective for tax years starting after December 31, 2024. This change simplifies tax treatment for those using private cord banking without altering insurance coverage or public banking access.